Heffernan Michael Thomas

CIK 000144891411 companiesSAINT-LAURENT

SEC Profile

Transactions

Companies

Filings

CIK

0001448914

Recent Transactions

50 trades

Award
enGene Therapeutics Inc.$ENGN
Stock Option (Right to Buy)
2026-06-16+31,000→ 31,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Nonstatutory Stock Option (right to buy)
2026-06-03+35,000→ 35,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-06-02+29,500→ 29,500 total
Award
Biohaven Ltd.$BHVN
Stock Options (Right to buy)
2026-04-28+68,693→ 68,693 total
Award
enGene Therapeutics Inc.$ENGN
Stock Option (Right to Buy)
2025-07-08+45,000→ 45,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-06-17+29,500→ 29,500 total
Award
Trevi Therapeutics, Inc.$TRVI
Nonstatutory Stock Option (right to buy)
2025-06-11+45,000→ 45,000 total
Award
Biohaven Ltd.$BHVN
Stock Options (Right to buy)
2025-05-05+31,716→ 31,716 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-03-25+50,000→ 50,000 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2025-02-10+4,820→ 50,328 total
Award
Trevi Therapeutics, Inc.$TRVI
Nonstatutory Stock Option (right to buy)
2024-06-13+30,000→ 30,000 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2024-05-16+7,693→ 45,508 total
Award
Biohaven Ltd.$BHVN
Stock Option (Right to Buy)
2024-04-30+16,592→ 16,592 total
Award
Trevi Therapeutics, Inc.$TRVI
Nonstatutory Stock Option (right to buy)
2023-06-28+30,000→ 30,000 total
Award
SYNLOGIC, INC.$SYBX
Stock Option (right to buy)
2023-06-22+30,000→ 30,000 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2023-05-18+9,792→ 37,815 total
Award
Biohaven Ltd.$BHVN
Stock Option (Right to Buy)
2023-05-02+52,906→ 52,906 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-27$16.15/sh+3,820→ 31,843 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-27$23.63/sh−15,995→ 28,023 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-27−15,995→ 3,820 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-27−3,820→ 0 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-27$24.16/sh−3,820→ 28,023 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-27$16.15/sh+15,995→ 44,018 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-23$16.15/sh+4,989→ 33,012 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-23−4,989→ 19,815 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-23$23.00/sh−4,989→ 28,023 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-22−237→ 24,804 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-22$16.15/sh+237→ 28,260 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-22$23.00/sh−237→ 28,023 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-21$23.11/sh−46,600→ 28,023 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-21$16.15/sh+46,600→ 74,623 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-21−46,600→ 25,041 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-20$16.15/sh+33,758→ 61,781 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-20−33,758→ 71,641 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-20$23.08/sh−33,758→ 28,023 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-19−3,606→ 105,399 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-19$23.04/sh−3,606→ 28,023 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-19$16.15/sh+3,606→ 31,629 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-13−7,904→ 0 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-13−59,524→ 0 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-13$22.16/sh−161,687→ 28,023 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-13$15.27/sh+94,259→ 181,806 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-13$14.90/sh+59,524→ 87,547 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-13−94,259→ 0 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-13$14.57/sh+7,904→ 189,710 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2022-12-12−1,510→ 0 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-12$14.57/sh+1,510→ 55,943 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-12$14.90/sh+10,669→ 38,692 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-12-12$22.01/sh−27,920→ 28,023 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)t to
2022-12-12−15,741→ 0 total

Companies

Recent Filings

Address

C/O 4868 RUE LEVY, SUITE 220

SAINT-LAURENT, H4R 2P1

View on SEC.gov